Muscle stem cells (MuSCs) are an essential adult stem cell population with the capacity to self-renew and regenerate muscle tissue. Functionally heterogeneous subpopulations of MuSCs have been identified based on their expression of myogenic regulatory factors and surface markers. However, a unified organization of muscle stem and progenitor cells and their subpopulations remains unresolved.
Introduction
Muscle stem cells (MuSCs), also known as satellite cells, are essential for skeletal muscle homeostasis and regeneration throughout lifespan (Blau et al., 2015; Wang and Rudnicki, 2011) . MuSCs are found at the periphery of the muscle myofibers and are sheltered inside a niche microenvironment where they are maintained in a quiescent state. In response to injury, MuSCs activate, self-renew, and differentiate into progenitors capable of myofiber repair. This regenerative process is orchestrated by a network of interactions with a variety of cell types including immune cells, endothelial cells, and fibro/adipogenic progenitors (FAPs) (Wosczyna and Rando, 2018) . For example, FAPs secrete fibronectin, insulin-like growth factor-1, and other matrix proteins and growth factors to coordinate muscle tissue repair through the regulation of myogenic cell fates and the clearance of cellular debris (Heredia et al., 2013; Joe et al., 2010; Lukjanenko et al., 2016) .
A continuum of myogenic stem and progenitor cell populations are present in regenerating muscle (Motohashi and Asakura, 2014; Tierney and Sacco, 2016) . MuSCs are quiescent Pax7-expressing cells in homeostasis and, following injury, progress in the cell cycle and exhibit an activated myogenic expression program marked by expression of Myf5 (Wang and Rudnicki, 2011) . Following cell division, their progeny either self-renew to replenish the Pax7 + MuSC pool or differentiate into MyoD + myogenic progenitors (myoblasts), which later commit to fusion-competent Myogenin + myocytes. This concept of the myogenic cell lineage was largely derived from lineage tracing and prospective isolation studies using myogenic regulatory factors and cell cycle to define cell states (Biressi and Rando, 2010) . Myogenic stem/progenitor cells populations, purified through surface antigen profiles and/or transgenic reporters, exhibit substantial molecular and functional heterogeneity throughout adulthood (Chakkalakal et al., 2014; Cornelison and Wold, 1997; Cosgrove et al., 2014; Kuang et al., 2007; Porpiglia et al., 2017; Rocheteau et al., 2012; Sacco et al., 2008; Sousa-Victor et al., 2014; Tierney et al., 2018) . These findings we organized more than 3,200 individual myogenic cell transcriptomes in a pseudo-time continuum to reveal their hierarchical organization and identify regulatory factor and surface marker expression profiles unique to distinct myogenic subpopulations. Finally, we used a ligand-receptor synchronous coexpression model to identify cell communication interactions between non-myogenic cells and distinct myogenic subpopulations involved the muscle repair process.
Results

A single-cell RNA-sequencing atlas of muscle regeneration
Skeletal muscle regeneration in response to local tissue damage depends on the coordinated interactions of multiple myogenic and non-myogenic cell types over a time-course of weeks (Wosczyna and Rando, 2018) . To gather a comprehensive view of this process, we generated transcriptomic atlas of adult mouse hindlimb muscle regeneration using droplet-based single-cell 3' RNA-sequencing (scRNA-seq) on the 10X Chromium platform. We collected tibialis anterior (TA) muscles of healthy adult (4-6 month) C57BL6 mice at 0, 2, 5, and 7 days following injection of the myotoxin notexin to induce myofiber damage (n=2-3 mice per time-point). We dissected and then enzymatically digested the TA muscles into single-cell suspensions and then filtered to remove cellular debris and, in some samples, applied red blood cells (RBC) lysis before performing scRNA-seq ( Fig. 1A) .
We used the Seurat package for scRNA-seq data filtering and processing (see Methods). We removed cells with fewer than 200 genes detected, fewer than 1000 UMIs, or with more than 20% of UMIs mapped to mitochondrial genes ( Fig. S1-1A-B ). Applying these filters eliminated erythroblasts to levels similar to those observed in samples where RBC lysis was performed, suggesting that the RBC step could be omitted ( Fig. S1-1D ). We found that the use of Calcein-AM based FACS sorting to enrich for viable cells altered the cellular composition. Specifically, cell sorting based on Calcein-AM positivity decreased the incidence of myogenic (MuSCs and progenitors) and anti-inflammatory macrophage populations ( Fig. S1-2) . This is could be due to biases introduced by viability selection, perhaps owing to reduced metabolism of Calcein-AM by quiescent cells. Based on this observation, we omitted FACS viability sorting in the collection of these scRNA-seq data.
After filtering, the scRNA-seq datasets each contained on average 3,444 ± 1,286 cells. We compared time-point replicate datasets generated from different mice (n=2-3) to evaluate batch effects and mouse-to-mouse variability. We observed only minor differences, most notably a small variation in the incidence of macrophage population in day 7 post-injury samples ( Fig. S1-1C ), suggesting that these datasets contained minimal batch effects. Thus, for subsequent analyses, we combined time-point biological replicates, without batch correction, to improve cell sample size and statistical power. Initially, the samples were assembled into a unified transcriptomic atlas containing 34,438 cells, expressing a Figure 1 (previous page). Assembly and curation of a scRNA-seq atlas of muscle regeneration. (A) Experimental design overview. Cell suspensions were collected from digested tibialis anterior (TA) muscles of adult mice at various time points (0, 2, 5, and 7 days) following notexin injury (n=2-3) and subjected to scRNA-seq and mass cytometry (CyTOF), followed by downstream analyses. (B) Complete 34,438 cell transcriptomic atlas assembled from all sample time-points. Data is presented as a UMAP projection used to visualize variation in singlecell transcriptomes. Unsupervised SNN clustering resolved at least 12 distinct types of cells (color-coded in legend). More resolved cell type clusters, distinguishing Neural/Glial from Schwann cells, immature B from cytotoxic T cells, were evident when analyzing time-points individually (see Fig. 2A ). (C) Identification of cell types from SNN clusters based on cluster-average expression of canonical genes. Dot size represents the percentage of cells with a nonzero expression level and color-scale represents the average expression level across all cells within cluster. total of 19,584 detectable genes (Figs. 1B and S1-1A). We next annotated the cell types involved in this muscle regeneration atlas. We employed uniform manifold approximation and projection (UMAP) to visualize the individual transcriptomes of all cells in the unified dataset ( Fig. 1B) (Becht et al., 2018) .
Independently, we performed unsupervised shared nearest neighbor (SNN) clustering, which partitioned cells into 12 groups based on their transcriptomic programs ( Fig. 1B) . We observed more refined groups, potentially revealing additional subtypes and cell states, when SNN clustering was applied to samples collected at individual time-points (see Fig. 2 ). In examining the full atlas, we interpreted the clusters as broadly defining 12 different cell populations. To identify these populations, we examined the normalized expression level and frequency of canonical cell type genes and named them based on their exclusivity in these expression patterns (Fig. 1C) . To discriminate more ambiguous populations, especially in the immune subpopulation, we performed differential expression analysis using a negative binomial model between cells within the cluster and all other cells in the atlas (Figs. S1-3 and S2-1).
We observed a population of myogenic progenitors, containing MuSCs and myoblasts, which expressed the myogenic transcription factors Pax7 and Myod1 (Wang and Rudnicki, 2011) . We detected a population of mature myocytes and/or myofibers, which expressed Myh1 (myosin heavy chain 1) and Acta1 (skeletal muscle alpha actin 1), both proteins involved in the contractile function of terminally differentiated skeletal muscle cells (Lyons et al., 1990) . The limited incidence of this population is likely due to the size-filtering out of multinucleated myofibers during the cell isolation protocol. Acta1 is also expressed, but at a lower level and frequency, in other cell types, which is not surprising given that it is a common component of the cytoskeleton and plays a role in cell migration. We also identified a population of Pdgfra-expressing fibro/adipogenic progenitor cells (FAPs) (Uezumi et al., 2011) and tendon progenitor cells (tenocytes), which express the tenogenic transcription factor Scx (scleraxis), and glycoprotein encoding genes Fmod (fibromodulin) and Tnmd (tenomodulin) (see Fig. S2 ) (Docheva et al., 2005; Schweitzer et al., 2001) . Two closely related Pecam1 (cell adhesion molecule CD31)-expressing populations were identified as, first, smooth muscle cells (SMCs) and mesenchymal progenitors that exclusively express Myl9 (myosin light chain 9) (Gaylinn et al., 1989 ) and, second, endothelial cells that express Cdh5 (cadherin 5) (Christov et al., 2007; Zordan et al., 2014) . We also find a mixed group of neuro-muscular cells, which are enriched for expression of the Schwann cell marker Mpz (myelin protein zero) and the neuronal gene Ptn (pleiotrophin) (Liu et al., 2015) .
The cumulatively largest and most ambiguous group are immune cells, which dynamically infiltrate muscle and mediate inflammatory regulation of tissue repair. We observed substantial overlap in immune cell marker gene expression ( Fig. 1C) , which agrees with the immune cell phenotype continuum model (Novak and Koh, 2013) . We therefore examined multiple gene signatures to subdivide immune cell clusters (Figs. S1-4 and S2-1) based on prior literature (Chazaud, 2016; Tidball, 2017) . One immune cluster contains resident macrophages and antigen presenting cells (APCs), as identified by expression of Cd74 and other MHCII complex encoding genes. A second immune cluster contains a general group of monocytes, macrophages, and platelets, marked by expression of Cd68 (common immune glycoprotein CD68) and Pf4 (platelet factor 4). A third immune cluster contains activated (proinflammatory) macrophages as identified by expression of the inflammatory neutrophil and macrophage markers including Ccl6 (chemokine C-C motif ligand 6). A fourth immune cluster contains antiinflammatory macrophages, as identified by expression of C1qa, which encodes for part of the C1 complement complex. A fifth immune cluster contains immature and mature B-and T-lymphocytes and NK cells, as identified by expression of the common lymphocyte gene Ptprc (protein tyrosine phosphatase receptor type C, or CD45) and Nkg7 (natural killer cell granule protein 7). This annotated scRNA-seq dataset provides a reference atlas to examine the cell populations and gene expression dynamics during muscle regeneration.
Cell type and gene expression dynamics of muscle regeneration at single-cell resolution
Next, we analyzed the transcriptomic atlas to assess how these populations are dynamically altered in incidence and gene expression activity following muscle injury. Overall, we discerned between 5-12 distinct cell populations via SNN clustering at each time-point ( Fig. 2A-B ). Uninjured muscles (day 0) were largely composed of endothelial cells, FAPs, and mature myocytes/myonuclei, with other cell populations detected infrequently. After injury, we observed a transient increase in multiple immune cell types and a concomitant decline in non-immune populations. By day 5, the immune cell population diversified while the myogenic populations recovered. By day 7, most cell populations approached their day 0 frequencies and gene expression states (Figs. 2C, S2-1, and S2-2), revealing a return to homeostasis.
Pecam1-expressing endothelial cells were the most abundant cell population at day 0 (38%) and exhibited only minor changes in detection frequency and gene expression heterogeneity throughout the time-course (Christov et al., 2007) . In contrast, Pdgfra-expressing FAPs exhibited compositional and expression variability. FAPs were a substantial cell fraction of uninjured muscles (31%) and expressed respectively, 7,025, 5,524, 14,240, and 7,646 cells for day 0, 2, 5, and 7 days post-notexin injury. Fourteen total cell types were identified using SNN clustering applied to each time-point. Cells from other time-points are in gray. (B) Compositional dynamics of cell types throughout the regeneration time course. Immune cells are grouped together (top) or separated (bottom). (C) Violin plots presenting the heterogeneous gene expression changes for a selection of differentially expressed genes within the endothelial, FAP, and MuSC/myogenic progenitors populations at each time-point. MuSCs and myogenic progenitor cells were too rare at day 2 to analyze. the ECM genes Col3a1, Dcn, and Gsn in homeostasis ( Fig. 2A-C, S2-1, and S2-2) . At day 2 post-injury, FAPs also express Ccl7, Cxcl5, and Cxcl1, chemokines that attract monocytes and neutrophils. FAPs have elevated expression of Col1a1, Col1a2 and Mt and diminished expression of Gsn and Dcn, suggesting an "activated" or "remodeling" state ( Fig. S2-2) . At day 5, FAPs have further elevated expression of Col1a1 and Col1a2 and also express Postn, Bgn, and Sparc (Fig. 2C) . At day 7, the FAP expression profile resembles the uninjured samples, albeit with more heterogeneity, indicating a resolution to homeostasis ( Fig. S2-2) .
Likewise, the immune cell populations within this atlas exhibit notable dynamics. At day 0, we detect that immune cell populations comprise 5% of the uninjured muscle, and can be subdivided into a more defined group of Cd79 + Ly6d + immature myeloblasts, Cd3 + T-cells, and a group of resident macrophages and APCs expressing Lyz2, Cd74, and Ccl6 ( Fig. S1-2 , S1-3). At day 2, the inflammatory response initiates, as reflected by a dramatic increase in the frequency (84%) of immune cells detected ( Fig. 2A) . This early-response immune compartment can be divided into three populations. First, we observed APCs characterized by expression of MHC class II proteins such as Cd74 and the H2 family.
Within this group we distinguish small populations of Cd7 + mature T-cells, Klrd1 + NK cells, and Cd209a + dendritic cells. Second, we identified pro-inflammatory macrophages (including activated M1-like macrophages) that express Ccl9 (a chemokine that attracts Cd11b + Ccr1 + dendritic cells), Ccr2 (a chemokine involved in monocyte chemotaxis), and Ly6c2. Third, we observed a less defined group of cells that express a wide variety of markers including Cd68 + monocytes and Pf4 + platelets ( Fig. S1-4 , S2-1). At day 5 post-injury, immune cells still are remain prevalent (64%) ( Fig. 2A) . We observed however a shift in the macrophage population from a pro-inflammatory to an anti-inflammatory phenotype. We found that these macrophages express C1q complement genes as well as Apoe, characteristic of the M2-like anti-inflammatory phenotype (Baitsch et al., 2011; Ho et al., 2016) . We detect some Aif1 + macrophages and/or dendritic cells that have been reported to modulate muscle repair (Kuschel et al., 2000) . We found elevated frequencies of APCs, Lsp1 + Ccr7 + B-cells, Ccl5 + Xcl1 + T-cells and Nkg7 + Klrd1 + NK cells. (Fig. S2-1) . At day 7, immune cells were more infrequent (17%) and started to resemble their day 0 cell type composition, with some M2-like macrophages, T-lymphocyte and NKcells remaining.
The myogenic cell populations exhibited a temporal profile inverted in abundance relative to the immune cells and transcriptionally heterogeneous. At day 0, we detected a small population (2%) of MuSCs and progenitor cells expressing Pax7, Sdc4, Vcam1, and Myod1, and also detected Acta1 + Myl1 + mature myocytes and/or myofiber nuclei (9%). At day 2, we did not detect any MuSCs or progenitors though they are reported to be in an activated state following notexin injury. This surprising finding is likely due the relative rarity of myogenic cells compared immune cells providing a sampling challenge at this time-point. At day 5, we observed a large expansion of the MuSC and progenitor population (12%) and decline of the myocyte population (1%) as expected. This population heterogeneously expresses lower levels of Pax7, Vcam1, and Sdc4, higher levels of Myod1, Des, Mest, and the mitotic gene Cdkn1c, suggesting they include more frequent cells in an activated and/or proliferating state (Fig. 2C) . This population also induces expression of Igfbp5, known to regulate myogenic differentiation (Ren et al., 2008) . At day 7, the myogenic cell population remains in a heterogeneously activated and differentiation state with some recovery of Pax7 + MuSC population ( Fig. 2C) .
Lastly, some cell populations were almost exclusively found at days 0 and 7. We observed a small (3%) population of tenocytes that express the canonical marker Scx (scleraxis) as well as Tnmd (tenomodulin), Fmod (fibromodulin), and Thbs4 (thrombospondin) (Giordani et al., 2019) (Fig. S1-3) . We also observed two closely related populations of mesenchymal progenitors and smooth muscle cells, which were distinguished based on their expression of Myh11 and Acta2. In a similar manner, Schwann cells (enriched for Mpz, Mbp, Fxyd3, and Prx) were distinguished from other related neural and glial cells (enriched for Ptn, Postn, Cadm1, Lyz2 and Col20a1) ( Fig. S1-3 ).
Single-cell trajectory inference organizes a myogenic cell continuum involved in muscle regeneration
The consensus model of adult muscle regeneration states that a subset of MuSCs leave quiescence after tissue damage and enter an activated cycling state to generate progeny through a combination of asymmetric and symmetric division events (Wang and Rudnicki, 2011) . These myogenic progenies adopt multiple fate trajectories, including return to Pax7 + quiescent MuSCs, differentiation into a proliferative Pax7 -Myf5 + Myod1 + myoblast progenitors, or commitment into Myog + fusion-competent myocytes. We asked whether unbiased analyses could reconstruct this consensus model and provide into new insights into the continuum of myogenic cell-states.
First, we explored the cellular heterogeneity within the cumulative myogenic cell population by selecting the MuSCs, progenitors, and mature myocytes from the unified transcriptomic atlas. Unbiased SNN clustering revealed five sub-populations of myogenic cells (Fig. S3A) . These subpopulations clarify the myogenic heterogeneity in two ways: across post-injury time-points and within the stage of differentiation (Fig. S3B) . Cluster 5 is comprised of terminally differentiated myocytes expressing elevated levels of Acta1 and Myh1 from all time-points, whereas clusters 1-4 represent a heterogeneous population of MuSCs and their progeny. Cluster 1 contains cells from both from days 0 and 7 post-injury and is largely enriched for Pax7, Sdc4, Vcam1, and Cd34 transcripts, therefore are likely quiescent MuSCs (Fig. S3C) . Clusters 2, 3, and 4 contain cells from days 5 and 7 post-injury and that heterogeneously express the myogenic activation and commitment markers Myf5, Myod1, and Myog and have reduced expression of MuSC markers, suggesting these each contain a mixture of activated MuSC and myoblasts. Notably, clusters 2-4 likely represent a varied but sequential transition towards myogenic commitment, which is exemplified by stepwise elevation in Myog expression ( Fig. S3C) . Therefore, we conclude that cluster 4 is comprised of committed myoblasts whereas clusters 2 and 3 primarily contain activated MuSCs. These clusters describe an organized partitioning of the myogenic cell population.
Next, given that SNN clustering lacks hierarchical structure, we sought to organizing these subpopulations using a trajectory inference model to delineate their interrelatedness. We applied Monocle reverse graph embedding (Qiu et al., 2017) to the cumulative myogenic cell population within the atlas to infer a hierarchical trajectory (Figs. 3A) . The Monocle analysis focused on differentially expressed genes within one of these five myogenic clusters and aligns cells into a one-dimensional "pseudo-time" axis. The pseudo-time trajectory presented an organized, branched progression of cells from quiescent MuSCs to cycling and differentiating progenitors to terminally differentiated myocytes, which can be seen by labelling individual cells using the cell population annotations from the unified atlas ( Fig. 1B) . Both the beginning and ending branches within the trajectory are composed of cells from days 0 and 7 post-injury, indicated they consist of Pax7 hi quiescent MuSCs and Acta1 hi terminally differentiated myocytes, respectively, which are both absent at intermediate time-points (Fig. 3A) . A subset of cells diverts at the central node into a third branch comprised of day 5 and 7 post-injury cells enriched for Cdk1
and Cdc20, indicating that they are actively cycling myoblasts. Near the central node, we observed day 5 and 7 post-injury cells that expressed myoblast and myocyte markers such as Myog and Myod1 (not shown). We interpret this branch structure as a bidirectional trajectory in which activated and cycling progenitors (predominantly from day 5 post-injury) can bifurcate either towards further commitment into terminal myocytes needed for myofiber repair or towards a return to quiescence.
Then, we performed a differential expression analysis along the pseudo-time axis in order to identify genes that explain this myogenic cell progression (Fig. 3B) . The top 86 differentially expressed genes partition in four clusters that are distinguished by their pseudo-temporal gene expression patterns (see Methods). The "early" gene cluster contains quiescence-associated MuSC genes, including Pax7, Id3 (a direct target of Pax7 and inhibitor of myogenic activation differentiation), Mt2, Klf4 (a potent inhibitor of smooth muscle differentiation), and cell cycle inhibitor Btg2 (which has been shown to interact with Id3 to regulate neural progenitor cell differentiation) (Farioli-Vecchioli et al., 2009; Kumar et al., 2009 ). The first "intermediate" gene cluster group contains activation-and cycling-associated genes, including Myod1, Hmgb2 (regulates MuSC differentiation through Igf2), as well as multiple mitotic genes such as the cyclin-dependent kinases Cks2 and Cdk1, Smc4 (essential to condense chromatin), and the antiapoptotic gene Birc5. The second "intermediate" gene cluster contains commitment-associated genes such as the cyclin-dependent kinase inhibitor Cdkn1c, the myogenic differentiation regulator Igfbp5 (Ren et al., 2008) , and genes encoding transmembrane proteins Cdh15, Itm2a, Cd82 and Cd63. The "late" gene cluster contains terminal differentiation-associated genes such as Myl1, the troponin family complex members (e.g., Tnni2), and metabolic enzymes Gyg and Ak1 (Janssen et al., 2000) .
Last, we analyzed the trajectory of the myogenic stem/progenitor cell population (other cell types excluded from this analysis, Fig. 3C-D and S3D) . This refined trajectory model identifies three branches of immature myogenic cells within the transcriptomic atlas ( Fig. 3C-D) , distinguished by their quiescent ("Qu"), cycling ("Cy"), and non-cycling committed ("Co") signatures. The "Qu" branch is enriched for Btg2 and Id3 expression, whereas the "Cy" branch is enriched for G2-state mitotic genes Cdk1, Cdc20, and Ccnb2, and the "Co" branch, is enriched for the cell cycle inhibitory genes Cdkn1c and Myog (Fig. 3D and S3E). When visualized with respect to the pseudo-time progression axis, these genes help distinguish between cells likely to project into "cycling" and "committed" cell fates (Fig. 3D) For a given receptor-ligand pair, we only represent interactions whose score (Fig. S4) is greater than the 50 th percentile across all cell types. (B) Sdc1/2/3/4 and Ccnb1 (Cyclin-B1) transcript averages across all non-mature myogenic cells within the transcriptomic atlas, split by days post-injury (see Fig. 3C ). p-values listed if differentially expressed across time-points when modeled using a negative binomial distribution. (D, left) CyTOF atlas, consisting of 19,028 cells collected from regenerating (day 5 post-injury) muscles and stained with a panel of 35 antibodies (see Table  S1 ) including Syndecan-1/2/3/4 and Cyclin-B1. UMAP and unsupervised SNN clustering identified 11 populations including a population of Pax7 + MuSCs (orange) and Myog + myogenic progenitors (blue). These two myogenic clusters were grouped for further analysis. (D, right) Cyclin-B1 versus Pax7 scatter plots. Top coded using CyTOF SNN cluster identifiers. Bottom, coded by sub-population gates: Cyclin-B1 -Pax7 + quiescent cells (Qu; pink), Cyclin-B1 + cycling progenitors (Cy; blue), and Cyclin-B1 -Pax7committed myocytes (Co; green). (E) expression histograms for Syndecan-1/2/3/4 and other myogenic markers for the three subpopulations identified in (D).
Diversification of Syndecan receptor expression in myogenic stem and progenitors provides stage-specific heterotypic cell communication channels
Cell communication signals, acting through secreted ligands binding to receptors on muscle stem and progenitor cells, govern a multitude of cell-fate regulation mechanisms critical for muscle homeostasis and regeneration (Yin et al., 2013) . To explore the dynamic cell communication network governing muscle repair, we generated a model that scores for interactions between receptors expressed by nonmature myogenic cells and ligands expressed by other cell types. We reasoned that this model could identify ligand-receptor co-expression pairs that provide "insulated" heterotypic cell-cell interactions potentially influencing cell-fate outcomes in myogenic cells but no other cell types in muscle. First, we considered possible ligand-receptor pairs from a database containing 2,009 mouse intercellular interaction signals (Skelly et al., 2018) . Second, we identified receptor genes from this list that are differentially expressed in the myogenic stem/progenitor cell populations relative to all other cells within the transcriptomic atlas at any time-point. Third, we calculated interaction scores by multiplying the average transcript expression value of each differentially expressed receptor gene in the myogenic stem/progenitor cell populations by the expression value of each cognate ligand gene (averaged over all cells within each other annotated cell population). We note this model does not consider spatial proximity between cell types, whether proteins are expressed, or whether the putative interaction pairs are documented specifically within myogenic cells.
Our model identifies 63 and 158 ligand-receptor pairs for the uninjured and injured (days 5 and 7 post-injury, combined) muscles, respectively, and 87 of these pairs were unique to injured samples (Fig.   S4 ). We only select interactions where the receptor is differentially expressed in the MuSC and progenitor population. Moreover, for each pair, we consider the interaction significant when the score is greater than the 50 th percentile when compared to all cell types. We represent significant interactions by a pairwise chord plot (Fig. 4A) . In uninjured muscles, the majority of these pairs involve myogenic cell expression of receptor genes Fgfr1, Fgfr4, Sdc4, Tgfbr3, Cd63 or Cd82, consistent with findings that MuSCs express diverse members of the FGFR, Syndecan (Sdc), TGF-β and tetraspanin families (Pawlikowski et al., 2017) . Notably, Fgfr1 and Fgfr4 interactions are mediated by a diverse set of 15 FGF ligand genes expressed across multiple cell types (mature skeletal myocytes, FAPs, tenocytes, and neural/glial/Schwann cells), suggesting broad redundancy in FGFR signaling interactions in uninjured muscles (Fig. S4) . This ligand-receptor promiscuity is also exemplified by the pairs involving Sdc4, the only Sdc gene differentially expressed by myogenic cells with uninjured muscles, which involve multiple ligand genes from various cell types including Ccl5 (myeloid progenitors), Thbs1 and Tnc (tenocytes), Fgf2, Tfpi, Mdk, and Rspo3 (FAPs), Tgm2 and Cxcl12 (SMCs), and Adam12 (neural/glial cells), and Fgf6 (mature myocytes). In the injured muscle we observed a diversification in the ligand-ligand interaction landscape, highlighted by inclusion of additional myogenic cell receptor genes (Sdc1, Sdc2, Notch1, Notch3, and Cd151) within the interaction pairs. Given the observed frequent and diverse involvement of Sdc receptor genes in these coexpressed ligand-receptor scores and their documented role in MuSC regulation (Pisconti et al., 2012) , we asked whether Sdc genes exhibit stage-specific expression patterns within the myogenic compartment of the transcriptomic atlas. We performed differential expression testing on the non-mature myogenic cell populations within the transcriptomic atlas between the day 0, 5, and 7 samples, and found that Sdc1 and Sdc2 were elevated at day 5 post-injury (along with the cycling MuSC gene Ccnb1), and Sdc4 was elevated in the uninjured muscle (Fig. 4B) . Further, Sdc1 and Sdc2 have enhanced expression in the Ccnb1 hi "Cy" branch of the Monocle trajectory (Fig. 4C) .
We validated Syndecan expression variation at different stages of the myogenic hierarchy through an independent analysis based on multiparameter mass cytometry (CyTOF). We immunostained a single-cell suspension from digested muscles at 5 days post-notexin injury using a panel of 35 antibodies (including the four Sdcs) to label myogenic and other cell types. After gating for live cells and removing debris (Fig. S5) , the CyTOF data was analyzed using a similar bioinformatic pipeline as for scRNA-seq datasets. Unsupervised SNN clustering revealed 11 subpopulations of cells including endothelial cells, FAPs, macrophages, lymphocytes, mesenchymal progenitors, an unresolved group of Cd9 + cells, and two myogenic populations (Fig. 4D) . One myogenic population consists of Pax7 + MuSCs whereas the other consists of Myog + myoblasts and myocytes (Fig. 4D) . These myogenic populations were merged, and sub-populations were gated into Cyclin-B1 -Pax7 + quiescent cells, Cyclin-B1 + cycling progenitors, and Cyclin-B1 -Pax7committed myocytes (Fig. 4E) . We observed that these three sub-populations uniformly express the myogenic surface marker Integrin-ɑ7 but have heterogeneous expression of Sdcs.
In particular, Sdc-1 hi and -2 hi cells are enriched in the cycling progenitor sub-populations. Taken together, these observations suggest that the transient induction of Sdc-1 and -2 in cycling (Cyclin-B1 + ) muscle progenitors may allow for diversified engagement with an exclusive set heterotypically secreted ligands in regenerating, but not uninjured, muscles.
Discussion
Combined with the development of increasingly complex computational methods, scRNA-seq has emerged as a powerful tool to profile the transcriptome of thousands of individual cells in one experiment (Stuart and Satija, 2019) . scRNA-seq analysis permits an unbiased survey of cellular complexity and heterogeneity with substantial experimental scope. Here, we leverage these recent developments to build a comprehensive temporal atlas of muscle tissue repair with over 34,000 single-cell transcriptomes, adding to the growing repository of single-cell skeletal muscle datasets.
To date, a handful muscle-focused scRNA-seq projects have been reported. The first study was performed on FACS-sorted Pax7-tdTomato + MuSCs using the Fluidigm C1 system (Cho and Doles, 2017) . Though limited to 21 single MuSCs, it provided a transcriptomic view of MuSC heterogeneity, highlighted enriched levels of Cd34 and Sdc4 transcripts. The study also highlighted some technical limitations, low recovery of Pax7 transcripts, which motivates the need to generate greater numbers of single-cell transcriptomes to allow more robust statistical analyses. Recently, Giordani et al. presented a transcriptomic atlas of 12,441 muscle-resident cells (Giordani et al., 2019) . Their study identified 10 distinct types of cells, including a population of Itga7 + Vcam1smooth muscle and mesenchymal cells (Porpiglia et al., 2017) . They identified two new surface markers, CD9 and CD104, that were used to describe two subpopulations of muscle progenitors, demonstrating how trajectory models from single-cell data can be used to discover new combinations of surface markers for the prospective isolation of MuSCs and their progeny.
Here, we present a unified and annotated single-cell transcriptomic reference atlas of muscle regeneration in adult mice. Our scRNA-seq and CyTOF analyses confirm prior consensus regarding the cell populations involved in the temporal response to muscle injury, and providing a deeper annotation of additional cell types, sub-populations and states with more resolved dynamics, compared to prior scRNAseq studies. We present comprehensive scRNA-seq dataset compendium describing a total of 34,438 cells (15 different cell types via SNN clustering) including 3,276 from MuSCs and mature muscle cells ( Figs. 1 and 2) . The complexity of this transcriptomic atlas powered development of a hierarchical continuum model of myogenic cell populations and receptor-ligand cell communication analysis (Figs. 3   and 4) . We also presented a CyTOF dataset composed of 35 markers to provide an orthogonal validation of myogenic sub-populations and their surface receptor expression variability. Trajectory analysis allowed us to parse the myogenic differentiation lineage post-injury in four distinct groups: quiescent MuSCs, cycling progenitors, committed progenitors, and mature skeletal muscle, with distinct gene expression signatures (Fig. 3) . Here we resolved that Id3 and Btg2 are both enriched in quiescent MuSCs with their expression decreasing following injury-induced MuSC activation and differentiation. Id3 is a DNA binding protein that has been found to be a direct target of Pax7 (Kumar et al., 2009) . Id3 is robustly expressed in quiescent MuSCs and blocks differentiation either by directly blocking the activity of pro-myogenic transcription factors such as Myf5, MyoD or by maintaining high levels of Hes1 (Kumar et al., 2009) . The role of Btg2 has not yet been previously described in myogenic cells. In hematopoietic and neural lineages, Btg2 promotes differentiation by inhibiting both Id3 and cyclin D1 to restrict cell cycle progression (Yuniati et al., 2019) . Though we did not identify the mechanism of Btg2 regulation of myogenic differentiation, these data suggest Btg2 and Id3 are distinct transcriptional markers of quiescent MuSCs.
We developed a cell communication model that allowed us to map interactions between MuSC receptors and ligands expressed by other cell types during muscle repair, which highlighted the complex role of Syndecan receptors in coordinating muscle progenitor heterogeneity. Syndecans (Sdcs) are transmembrane heparan sulfate proteoglycans that have been characterized as regulators of muscle development, homeostasis, and regeneration (Pisconti et al., 2012) . Previous studies have found that Sdc1 is only expressed in developing muscle, while the other muscle Sdcs (Sdc2, Sdc3, Sdc4) are expressed in MuSCs with differing post-injury expression dynamics specific to each receptor (Pisconti et al., 2012) . Sdc3 plays a role in maintaining MuSC quiescence, as Sdc3 -/muscles have do not atrophy, despite showing a loss in MuSC number, but have a homeostasis defect (Pisconti et al., 2016; Pisconti et al., 2010) . Sdc4, in contrast, seems to play a role in MuSCs activation through regulating FGF and HGF signaling (Cornelison et al., 2004) . Both our scRNA-seq and CyTOF data suggest that these four Sdcs are expressed heterogeneously with quiescent, cycling, and committed myogenic stem/progenitor cells (Fig. 4) . Sdc1, though previously thought not to be expressed in postnatal muscle, was detected both at the transcription and protein level, by scRNA-seq and CyTOF respectively, in activated cycling muscle progenitors and committed cells but not in MuSCs. Moreover, Sdc2 was expressed in some quiescent MuSCs and activated progenitors, Sdc3 expression was restricted to cycling MuSCs progenitors, and Sdc4 expressed in quiescent MuSCs and cycling progenitors alike. Together, these Sdcs provide a significant fraction of the heterotypic cell communication interactome, suggesting that temporal heterogeneity in Sdc expression may enable myogenic stage-specific fate regulation to a shared set of Sdc-binding ligands.
Though clustering and visualization approaches presented here and by others can be used to identify new cell types and biomarkers, we urge caution on how cell types are defined from these data.
First, single-cell data is not immune to technical imperfections such as doublets or sequencing reads that misalign (Stuart and Satija, 2019) . Second, single-cell data is sensitive to sample preparation methods, especially from the solid tissue sources. For example, we observed significant variability in the inclusion of tenocytes based on muscle-tendon resection precision (data not shown). We also found other biases introduced in the scRNA-seq composition introduced by FACS sorting can select for metabolically active immune cells. Furthermore, since scRNA-seq is based on RNA detection, some quiescent cell types such as MuSCs are challenging to unambiguously detect and will be benefited from in vivo transcript recovery advances (Machado et al., 2017; van Velthoven et al., 2017) . Even with these limitations, our scRNAseq study provides a view that discards some prior assumptions on the boundaries between myogenic cell types and suggests a myogenic continuum that is endowed with a plasticity of cell-cycle and commitment states. This annotated temporal scRNA-seq atlas of muscle regeneration may provide reference resource to examine the role cellular diversity and communication in aging, disease, and across species.
Methods
Mice and single-cell isolation. The Cornell University Institutional Animal Care and Use Committee (IACUC) approved all animal protocols and experiments were performed in compliance with its institutional guidelines. Adult C57BL/6J mice were obtained from Jackson Laboratories (#000664, Bar Harbor, ME) and were used at 4-5 months of age. To induce muscle injury, both tibialis anterior muscles received a single 10 µL intramuscular injection of notexin (10 µg/ml; Latoxan, France). At either 2, 5, or 7 days post-injury, one tibialis anterior muscle per mouse was collected to generate single-cell suspensions. Muscle were digested with 2.5 mg/ml Collagenase D (Roche) and 0.04 U/ml Dispase II (Roche) followed by manual dissociation, filtration, and red blood cell lysis to generate a single-cell suspension, as previously described (Cosgrove et al., 2014; Sacco et al., 2008) .
FACS sorting.
We used a fluorescence-activated cell sorter (FACS ARIA Fusion, BD Biosciences) to enrich the single-cell suspension for Calcein-AM + propidium iodideviable cells. The single-cell suspension was stained with Calcein-AM (1 µg per 100,000 cells) and PI for 30 min in PBS. Live cells were sorted selecting for Calcein-AM + and debris were removed using a standard FSC/SSC gating strategy.
Single-cell RNA-sequencing. After digestion, single-cells were washed and resuspended in 0.04% BSA in PBS at a concentration of at least 400 cells/μL. Cells were counted manually with a hemocytometer in order to determine the concentration. The single-cell RNA-sequencing library was then prepared using the Chromium Single Cell 3' reagent kit v2 (10X Genomics) in accordance with the manufacturer's protocol. Briefly, the cells were diluted into the Chromium Single Cell A Chip as to yield a recovery of ~6,000 single-cell transcriptomes with <5% doublet rate. Following the library preparation, the libraries were sequenced in multiplex (n=2 per sequencing run) on the NextSeq 500 sequencer (Illumina) to produce between 200 and 250 million reads per library and on average a minimum of 30,000 reads per single-cell.
Analysis of scRNA-seq data.
Sequencing reads were processed with the Cell Ranger version 3.0.1 (10X Genomics) using the mouse reference transcriptome mm10. From the gene expression matrix, the downstream analysis was carried out with R version 3.5.1 (2018-07-02). Quality control, filtering, data clustering and visualization, and the differential expression analysis was carried out using Seurat version 2.3.4 R package (Butler et al., 2018) with some custom modifications to the standard pipeline. Each of the 9 datasets were first analyzed independently before combining datasets from the same timepoint together for an integrated analysis. For each individual dataset, genes expressed in less that 3 cells as well as cells <1000 UMIs and <200 genes were removed from the gene expression matrix. In addition, we removed any single-cell with >20% UMIs mapped to mitochondrial genes, as well as obvious outliers in number of UMIs (cell doublets). After log-normalizing the data, the expression of each gene was scaled regressing out the number of UMI and the percent mitochondrial gene expressed in each cell. We performed PCA on the gene expression matrix and used the first 15 principal components for clustering and visualization. Unsupervised shared nearest neighbor (SSN) clustering was performed with a resolution of 0.4 and visualization was done using uniform manifold approximation and projection (UMAP) (Becht et al., 2018) . Finally, differential expression analysis was achieved using Seurat's "FindAllMarkers" function using a likelihood ratio test that assumes the data follows a negative binomial distribution and only considering genes with >log2(0.25) fold-change and expressed in at least 25% of cells in the cluster.
To analyze datasets merged from the same timepoint, we performed canonical correlation analysis (CCA) between datasets followed by data alignment using nonlinear dynamic time warping. We used the CCA matrix instead of PCA for visualization and clustering, and consequently, the differential expression analysis between clustered cells. The CCA space allows us to highlight shared patterns in gene expression profile between datasets. In addition, we did not observe significant differences in results between working in the CCA or PCA space, thus indicating little batch effect between samples from the same timepoint. We finally combined the 9 datasets into a uniform UMAP atlas using the CCA scores calculated from all the datasets. However, we retain the labels identified independently at each timepoint and the data was not re-clustered.
Monocle trajectory analysis.
We used the Monocle version 2.8.0 R package (Qiu et al., 2017) to organize cells in pseudo-time and infer new trajectories of MuSCs subpopulations post-injury. First, we subsetted the cells labeled as MuSCs and progenitor cells and Mature skeletal muscle from the Seurat dataset and across all timepoints and samples. Second, we performed unsupervised SNN clustering in order to identify new subpopulations in the data, from which we then used the Seurat "FindAllClusters" function (as described above) to find differentially expressed genes that characterize the subpopulations.
We then selected the top 150 genes based on fold-change expression with a minimum of log2(0.8) and
adjusted p-value of 0.1. This list genes of differentially expressed genes is then used by Monocle for clustering and ordering cells using the DDRTree method and reverse graph embedding. To identify genes that are differentially expressed across Monocle branches (States), we transferred the labels back to the Seurat dataset and performed differential expression analysis as described above.
Ligand-receptor cell communication model. The model aims at scoring potential receptor-ligand
interactions between MuSCs (receptor) and other cell types (ligand). We used the receptor-ligand interaction database from Skelly et al. (Skelly et al., 2018) . To calculate the score for a given receptorligand pair, we multiply the average receptor expression in MuSCs with the average ligand expression per other cell type (including MuSCs to consider for autocrine interactions). We only considered receptors that are differentially expressed in MuSCs at any given time-point post-injury.
CyTOF sample preparation and staining.
Most of the cell surface markers were obtained from Fluidigm and few others were conjugated in-house using the Maxpar X8 Multimetal Labeling Kit (see Table S1 for complete antibody list). The cells were stained with 50 μl of the antibody cocktail (100 μl of total staining volume) for 30 minutes at RT with intermittent vortexing. Following 2 washes (300g, 5 mins, RT), the cells were fixed with freshly prepared 1.6% PFA for 10 minutes. Thereafter, the cells were incubated for 30 minutes in 1 mL of the Nuclear Antigen Staining Buffer working solution. Then the cells were washed with 2 ml of Nuclear Antigen Staining Perm at 800g, 5 minutes, RT. 50 μl of nuclear antigen antibody cocktail was added to 50 μl of cell pellet solution and incubated for 45 minutes at RT. Following antibody staining, the cells were also stained with Cell-ID Intercalator-Ir-125 μM diluted to 1:1000 with MaxPar Fix and Perm buffer for 1 hour at RT. In addition, cells were also stained with 10 μl of Cisplatin for viability in 1 mL of pre-warmed serum free medium for 5 minutes at RT. Finally, cells were also stained with IdU (5-Iodo-2deoxyuridine) to label the S-phase at a concentration of 50 μM for 30 minutes at 37 o C.
CyTOF data acquisition and analysis. Cells were washed twice with staining buffer and then with MilliQ water. After the final wash, the cells were adjusted to a concentration of 10 6 cells/mL with 1:10 EQ beads to MilliQ water solution. Prior to the acquisition, the instrument was tuned and calibrated using the EQ standard beads. The acquisition speed of the sample was maintained within 400 events/seconds to avoid doublets and ion cloud fusion errors in the data. The output FCS files were normalized using the Fluidigm normalizer algorithm that is embedded within the CyTOF software (Version 6.7.1014). The CyTOF data was first gated using the Cytobank software in order to exclude debris, dead cells and doublets (Kotecha et al., 2010) . The resulting FCS file was then converted into a gene expression matrix using the Cytofkit R package using an inverse hyperbolic sine transformation (Chen et al., 2016) . The gene expression matrix was then analyzed with a Seurat-based custom pipeline, which allowed for SSN clustering and UMAP visualization.
Reagents and Resources
Antibodies Anti-Mouse CD8a (53-6.7)
Fluidigm 3153012B Figure S1-4. Expression of immune markers identified by differential expression analysis. Average expression of immune genes identified by differential expression analysis in the combined dataset (Fig. 1B) . These markers allowed delineation of 5 different immune cell populations pre and post-injury. The dot size represents the percentage of cells within a group with an expression level >0. (Fig. 3B) and ordered by branch and then pseudo-time progression. Figure S4 . Ligand-receptor interaction score heatmap. The heatmap represents score between receptors differentially expressed in MuSCs and progenitor cells and ligands on other cell types. Columns represent the cell type expressing the ligand and includes MuSCs and progenitors for autocrine interactions. Rows represent the ligand-receptor pair in the format LIGAND_RECEPTOR. The score for each pair has been normalized across ligand cell types with a positive value indicating that the pair has a high score for a particular ligand and cell type compared to other cell types. Figure S5 . Mass cytometry (CyTOF) atlas of uninjured and injured muscle-tissue cells. Gating strategy before generation of a gene expression matrix. Cells were discriminated from debris using 140Ce beads, then from doublets by the event length, and finally from dead cells using a viability marker (198Pt-negative). The resulting gated FCS file was transformed into a gene expression matrix scaling by an inverse hyperbolic sine transformation. 
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